Ticker

MongoDB (MDB) is experiencing a significant drop in pre-market trading, even after reporting a strong Q2 performance that exceeded expectations. Investors are c

Workday (WDAY) has seen its stock rise modestly following Q2 results that surpassed FactSet earnings expectations and slightly exceeded revenue estimates. Inves

Adamas Trust (NASDAQ: ADAM - Get Free Report) and ARMOUR Residential REIT (NYSE: ARR - Get Free Report) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Profitability This table compares Adamas Trust and

VERO BEACH, Florida, Aug. 27, 2026 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced the September 2026 cash dividend for the Company's Common Stock.

The Firmonertinib readout moving to H2 2026 may signal slower event accumulation and longer progression-free survival. Firmonertinib remains the core value driver, with our base case assuming meaningful penetration across EGFR exon 20 insertion and PACC populations. Pipeline optionality is expanding, with ARR-217 entering Phase 1 and ARR-002 approaching first-patient dosing.